Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Enanta Pharmaceuticals (ENTA) Current Assets (2016 - 2025)

Historic Current Assets for Enanta Pharmaceuticals (ENTA) over the last 14 years, with Q4 2025 value amounting to $198.7 million.

  • Enanta Pharmaceuticals' Current Assets fell 2590.43% to $198.7 million in Q4 2025 from the same period last year, while for Dec 2025 it was $198.7 million, marking a year-over-year decrease of 2590.43%. This contributed to the annual value of $204.3 million for FY2025, which is 3185.44% down from last year.
  • Latest data reveals that Enanta Pharmaceuticals reported Current Assets of $198.7 million as of Q4 2025, which was down 2590.43% from $204.3 million recorded in Q3 2025.
  • In the past 5 years, Enanta Pharmaceuticals' Current Assets registered a high of $448.5 million during Q2 2023, and its lowest value of $198.7 million during Q4 2025.
  • For the 5-year period, Enanta Pharmaceuticals' Current Assets averaged around $312.6 million, with its median value being $312.4 million (2022).
  • Per our database at Business Quant, Enanta Pharmaceuticals' Current Assets soared by 4326.35% in 2023 and then tumbled by 3609.67% in 2024.
  • Enanta Pharmaceuticals' Current Assets (Quarter) stood at $327.0 million in 2021, then dropped by 13.23% to $283.7 million in 2022, then skyrocketed by 37.57% to $390.3 million in 2023, then crashed by 31.3% to $268.1 million in 2024, then decreased by 25.9% to $198.7 million in 2025.
  • Its Current Assets stands at $198.7 million for Q4 2025, versus $204.3 million for Q3 2025 and $222.7 million for Q2 2025.